Mel Brodsky – Mortar and Pestle Award
Widespread Support for Ban on Part D Retroactive DIRs: NCPA and nearly 100 other pharmacy stakeholder organizations have expressed their support to the key lawmakers behind legislation that would prohibit retroactive DIR pharmacy fees on Medicare Part D clean claims.…